Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
About this item
Full title
Author / Creator
on behalf of the REPRIEVE Investigators , REPRIEVE Investigators , Grinspoon, Steven K. , Fitch, Kathleen V. , Overton, Edgar Turner , Fichtenbaum, Carl J. , Zanni, Markella V. , Aberg, Judith A. , Malvestutto, Carlos , Lu, Michael T. , Currier, Judith S. , Sponseller, Craig A. , Waclawiw, Myron , Alston-Smith, Beverly , Cooper-Arnold, Katharine , Klingman, Karin L. , Desvigne-Nickens, Patrice , Hoffmann, Udo , Ribaudo, Heather J. and Douglas, Pamela S.
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Cardiovascular disease (CVD) is more frequent among people with HIV (PWH) and may relate to traditional and nontraditional factors, including inflammation and immune activation. A critical need exists to develop effective strategies to prevent CVD in this population.
The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) (A5332) is a...
Alternative Titles
Full title
Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
Authors, Artists and Contributors
Author / Creator
REPRIEVE Investigators
Grinspoon, Steven K.
Fitch, Kathleen V.
Overton, Edgar Turner
Fichtenbaum, Carl J.
Zanni, Markella V.
Aberg, Judith A.
Malvestutto, Carlos
Lu, Michael T.
Currier, Judith S.
Sponseller, Craig A.
Waclawiw, Myron
Alston-Smith, Beverly
Cooper-Arnold, Katharine
Klingman, Karin L.
Desvigne-Nickens, Patrice
Hoffmann, Udo
Ribaudo, Heather J.
Douglas, Pamela S.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2228584911
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2228584911
Other Identifiers
ISSN
0002-8703
E-ISSN
1097-6744
DOI
10.1016/j.ahj.2018.12.016
